Oncodesign S.A. buy melinda
Start price
29.03.16
/
50%
€19.48
Target price
29.09.16
€21.00
Performance (%)
-10.11%
End price
29.09.16
€17.51
Summary
This prediction ended on 29.09.16 with a price of €17.51. The price of Oncodesign S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.11%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oncodesign S.A. | - | - | - | - |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
According to melinda what are the pros and cons of Oncodesign S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Oncodesign S.A. diskutieren
ALONC
Résultats 2015: réduction de la perte d'exploitation à -0,64M€, RN positif à +1,21M€, trésorerie nette à 9,2 M€
ALONC
(Laufzeit überschritten)
Stopped prediction by melinda for Oncodesign S.A.
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
24.12.22
24.12.22
-
24.12.23
24.12.23
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
23.12.22
23.12.22
-
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€8.61
08.12.21
08.12.21
€10.00
08.12.22
08.12.22
65.85%
09.12.22
09.12.22
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€10.08
09.10.21
09.10.21
€12.00
09.10.22
09.10.22
-20.04%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€13.05
27.01.18
27.01.18
€14.00
31.01.18
31.01.18
7.28%
31.01.18
31.01.18
Could be worthwhile Investment >10% per year